Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib
Kastritis, E, Gavriatopoulou, M, Roussou, M, Fotiou, D, Ziogas, D C, Migkou, M, Eleutherakis-Papaiakovou, E, Panagiotidis, I, Kanellias, N, Psimenou, E, Papadopoulou, E, Pamboucas, C, Manios, E, GakioVolume:
7
Language:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/bcj.2017.47
Date:
June, 2017
File:
PDF, 234 KB
english, 2017